REG - Ilika plc - First Customer Shipments of Stereax M300 Batteries

IlikaAnnouncement

11/05/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230511:nRSK9929Ya&default-theme=true

RNS Number : 9929Y  Ilika plc  11 May 2023

Ilika plc

("Ilika" or the "Company")

 

First Customer Shipments of Stereax® M300 Stacked Batteries

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces it
has made a number of first customer shipments of stacked Stereax® M300
batteries from its UK manufacturing facility. Further to its announcement of
11 April 2023, these shipments are the first of a series of planned deliveries
of Stereax M300 batteries to customers including CubeWorks, the developer of
millimeter-scale smart sensing solutions for IoT, and Lura Health, a leading
developer of wearable intraoral biosensors for salivary diagnostics. Stereax
batteries can be configured such that they can be stacked, which provides
customers with the flexibility to adapt the battery capacity for their
application.

 

The small form factor of M300 batteries is of particular interest to Ilika's
customers due to their compact, high-density and high-power characteristics.
CubeWorks is designing CubiSens(TM), a next generation sensing platform,
aiming to transform biopharma cold chain logistics, security control, asset
protection and environment monitoring.

 

Lura Health has developed the world's first salivary diagnostic, wearable
sensor, first embedded in traditional orthodontic appliances including
retainers, bands, and brackets, and eventually in prosthodontic appliances
including dentures, implants, and bridges. Worn in the mouth continually
throughout the day, it continually measures analytes in saliva, and provides
real time streams of health data by Bluetooth Low Energy to a smartphone.

 

Cirtec Update

Ilika and Cirtec Medical LLC ('Cirtec'), a strategic outsourcing partner of
complex medical devices including minimally invasive and active implantable
devices, are continuing to finalise the terms of their intended partnership.

 

Graeme Purdy, Ilika's Chief Executive Officer said: "Building on the first
shipments of Stereax M50 cells last month, our team has delivered the first
batches of Stereax M300 batteries to support our customers' product
development programmes. CubeWorks and Lura Health are strong examples of
breakthrough technology being enabled by Stereax products. We will work
closely with Cirtec to jointly market Stereax technology and ramp up
production capacity to support our customers' needs going forward."

 

Gyouho Kim, CubeWorks Chief Executive Officer, commented: "We are thrilled to
start integrating Ilika's breakthrough battery technology to further enhance
our CubiSens(TM) product lineup. Batteries have traditionally been one of the
major bottlenecks in IoT, and Ilika's battery technology offers a unique
balance of form factor and performance that can complement our ultra-efficient
SoC (System-on-Chip) solution to achieve exciting new products."

 

Daniel Weinstein, Lura Health Chief Executive Officer, commented: "Small form
factor is important in the design of Lura Health's salivary diagnostics
sensor. We are looking forward to qualifying Ilika's technology and
understanding its potential benefits to our future product road map."

 

 For more information contact:
 Ilika plc                                               www.ilika.com (http://www.ilika.com/)
 Graeme Purdy, Chief Executive                           Via Walbrook PR

 Liberum Capital Limited (Nomad and Joint Broker)        Tel: 020 3100 2000
 Andrew Godber,
 William Hall, Nikhil Varghese

 Joh. Berenberg, Gossler & Co. KG (Joint Broker)         Tel: 020 3207 8700
 Matthew Armitt, Mark Whitmore, Detlir Elezi,
 Mara Grasso

 Walbrook PR Ltd             Tel: 020 7933 8780 / Ilika@walbrookpr.com
 Lianne Applegarth                                       Mob: 07584 391 303
 Nick Rome                                               Mob: 07748 325 236
 Tom Cooper                                              Mob: 07971 221 972

 

About Ilika Technologies

Ilika specializes in the development of solid-state batteries. Its Stereax®
product line is designed for miniature medical devices and specialist internet
of Things (IoT) applications. Stereax® enables disruptive product designers
looking for an intrinsically safe, long life (1000s recharges), low leakage
(nA) and miniature power source in a rectangular form factor similar to ICs.
For more information about Ilika, please visit:  https://www.ilika.com
(https://www.ilika.com) .

 

About CubeWorks

CubeWorks brings to market a portfolio of ultra-low-power, ultra-small
wireless smart sensors. These sensors offer limitless potential across a broad
range of applications and provide access to mission-critical information
exactly when and where it is needed. For more information, please visit
https://www.cubeworks.io/ (https://www.cubeworks.io/)

 

About Lura Health

Lura Health's mission is to provide everyone with continual streams of
critical health data, anytime, anywhere, to prevent health emergencies, manage
chronic diseases, and achieve health goals. Lura Health and its founders have
received notable press-coverage from the Verge, TechCrunch Disrupt and Forbes
30 Under 30, and funding from National Science Foundation SBIR phase I and II
awards and SOSV, a $1B AUM deep-tech investment firm. Please visit
https://www.lurahealth.com/ (https://www.lurahealth.com/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEALSEFEDDEFA